This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Introduction: Fifty Years of Lithium Use in the Treatment of Bipolar Disorder

Charles B. Nemeroff, MD, PhD

Published: July 31, 2000

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Although lithium has been used in the treatment of various neuropsychiatric conditions in the past 3 decades, it is particularly beneficial for the acute and long-term treatment of mania and, in some bipolar and unipolar patients, for prophylaxis and treatment of depression. In recent years, however, young physicians have largely ignored the benefits of lithium in favor of anticonvulsant or atypical antipsychotic pharmacotherapy for patients with bipolar disorder. Moreover, while lithium was studied extensively in the past, recent literature shows a paucity of controlled studies of the drug.’ ‹’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: Bipolar Disorder

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...